HIV control efforts should directly address incarceration

Lancet Infectious Diseases

Volumn 7, Issue 9, 2007, Pages 568-569

  Maru, Duncan Smith Rohrberg ^a   Basu, Sanjay ^a   Altice, Frederick L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRIMINAL JUSTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LAW; LETTER; PRIMARY PREVENTION; PRIORITY JOURNAL; PRISON; PRISONER; PUBLIC HEALTH SERVICE; RISK FACTOR; RISK REDUCTION; SEXUAL BEHAVIOR; SOCIAL NETWORK; SOCIAL SUPPORT; SUBSTANCE ABUSE;

FEMALE; HIV INFECTIONS; HUMANS; MALE; PRISONERS; PRISONS; RISK-TAKING; SEXUAL BEHAVIOR;

EID: 34547962275     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70190-1     Document Type: Letter

References (15)

1. Dolan K., Kite B., Black E., Aceijas C., and Stimson G. HIV in prison in low-income and middle-income countries. Lancet Infect Dis 7 (2007) 32-41
2. Wallace R. Social disintegration and the spread of AIDS-II. Meltdown of sociogeographic structure in urban minority neighborhoods. Soc Sci Med 37 (1993) 887-896
3. Thomas J. From slavery to incarceration: social forces affecting the epidemiology of sexually transmitted diseases in the rural South. Sex Transm Dis 33 suppl 7 (2006) S6-S10
4. Adimora A., and Schoenbach V. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis 191 suppl 1 (2005) S115-S122
5. Harrison L. The revolving prison door for drug-involved offenders: challenges and opportunities. Crime Delinq 47 (2001) 462-485
6. Springer S., Pesanti E., Hodges J., Macura T., Doros G., and Altice F. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis 38 (2004) 1754-1760
7. McVay D., Schiraldi V., and Ziedenberg J. Treatment or incarceration? National and state findings on the efficacy and cost savings of drug treatment versus imprisonment (2004), Justice Policy Institute, Washington, DC
8. Chandler C., Patton G., and Job J. Community-based alternative sentencing for HIV-positive women in the Criminal Justice System. Berkeley Womens Law J 14 (1999) 66
9. Drucker E. Population impact of mass incarceration under New York's Rockefeller drug laws: an analysis of years of life lost. J Urban Health 79 (2002) 434-435
10. Glaser J., and Greifinger R. Correctional health care: a public health opportunity. Ann Intern Med 118 (1993) 139-145
11. Altice F., Sullivan L., Smith-Rohrberg D., Basu S., Stancliff S., and Eldred L. The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clin Infect Dis 43 suppl 4 (2006) S178-S183
12. Blankenship K., Smoyer A., Bray S., and Mattocks K. Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system. J Health Care Poor Underserved 16 suppl 4B (2005) 140-156
13. Courtwright D. The controlled substances act: how a "big tent" reform became a punitive drug law. Drug Alcohol Depend 76 (2004) 9-15
14. Kerr T., Kaplan K., Suwannawong P., and Wood E. Getting global funds to those most in need: the Thai Drug Users' Network. Health Hum Rights 8 (2005) 170-186
15. Jana S., Basu I., Rotheram-Borus M., and Newman P. The Sonagachi Project: a sustainable community intervention program. AIDS Educ Prev 16 (2004) 405-414